New coronavirus multi-component variant detection method based on lanthanide encoding DNA tetrahedral structure
Through trivalent DNA tetrahedral structure and ICPMS technology based on lanthanide macrocyclic compound labeling, combined with MNAzyme specific recognition, the problem of high sensitivity and multiple analysis cannot be achieved in multi-component detection of the new coronavirus is solved, and SARS-CoV- 2 The simultaneous detection of multiple variants significantly improves detection sensitivity and selectivity.
Patent Information
- Application Number
- CN202310499831.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-06
- Publication Date
- 2024-11-08
AI Technical Summary
The prior art is difficult to detect multiple variants of the new coronavirus simultaneously with high sensitivity, especially in multi-component detection, which cannot achieve effective multiple analysis.
A trivalent DNA tetrahedral structure based on lanthanide macrocyclic compounds was designed, combined with ICPMS technology, and the simultaneous detection of mutations such as HV69/70del, K417N, T478K were achieved through MNAzyme specific recognition and shearing. This method utilizes lanthanide isotope tags and magnetic bead satellite structures to improve the sensitivity and selectivity of detection.
The simultaneous detection of multiple variants of SARS-CoV-2, including Alpha, Beta, Delta and Omicron, has been realized, which significantly improves detection sensitivity and selectivity, and can accurately identify multiple variants at low concentrations, suitable for multiple, Scalable diagnostic screening.
Smart Images

Figure BDA0004213322740000041 
Figure BDA0004213322740000051 
Figure BDA0004213322740000061
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of analytical chemistry detection, and specifically relates to the field of stable isotope sensing based on DNA hybridization and MNAzyme specific recognition and shearing, and particularly designs a lanthanide macrocyclic compound (MMA-DOTA-Tb 3+ / Ho 3+ / Tm 3 )-labeled trivalent tetrahedral DNA nanostructures (tTDN) were used to selectively detect HV69 / 70del (α-specific), K417N (β-specific), and T478K (δ-specific) of the SARS-CoV-2S gene, as well as the Omicron variants that share the above mutations, achieving sensitive and simultaneous detection of the four variants. Background Art
[0002] Multiple variants of SARS-CoV-2 have shown increased transmissibility and pathogenicity. The U.S. Centers for Disease Control and Prevention (CDC) has now defined five strains of SARS-CoV-2Alpha / Beta / Gamma / Delta / Omicron as variants of particular concern. The mass spread of multiple SARS-CoV-2 variants has brought new challenges to molecular diagnosis, and multiple, scalable diagnostic screening of SARS-CoV-2 variants needs to be widely available to enable active monitoring and centralized patient care. To overcome this limitation, the present invention combines the low detection limit of Inductively Coupled Plasma Mass Spectrometry (ICPMS) (most elements can reach pg mL -1To address the need for affordable and accessible multiplexing, a trivalent DNA tetrahedron (tTDN)-magnetic beads (MBs) satellite with lanthanide isotope labels on the vertices was constructed for multi-component signature mutation detection of SARS-CoV-2. TDN provides a directional scaffold for subsequent reaction design, and it has the characteristics of increasing local concentration for nucleic acid reactions, improving sensitivity, and being easy to manufacture; in addition, the unique multi-vertex structure makes it an ideal platform for multi-component bioanalysis. Combining the advantages of TDN and elemental mass spectrometry in multi-component detection without spectral overlap of each element, we established a multi-antennary tTDN with pendant lanthanide isotope probes as MNAzyme substrates for multiplex analysis of HV69 / 70del (Alpha specific), K417N (Beta specific), and T478K (Delta specific), and can simultaneously identify variant Omicron (ο) containing these three mutations. The tTDN on the MBs provides a controllable nanoscale spatial distance, effectively reducing the nonspecific adsorption of the cantilever probe DNA. The splicing of the cantilever probe by MNAzyme can achieve RNA re-release, while the isotope label is continuously stripped like a de-orbiting satellite to achieve signal amplification, ultimately achieving simultaneous detection of triple SARS-CoV-2 variants. Summary of the invention
[0003] A method for detecting multi-component variants of the new coronavirus based on a lanthanide-encoded DNA tetrahedron structure is provided to address the insufficiency of existing methods in the multi-component detection of new coronavirus variants that cannot achieve simultaneous high-sensitivity determination. To achieve the above purpose, the present invention provides the following technical solutions: A method for detecting multi-component variants of the novel coronavirus based on a lanthanide-encoded DNA tetrahedron structure, characterized by following the following operating steps: a. Preparation of element-tagged lanthanide macrocyclic compounds (MMA-DOTA-Tb 3+ / Ho 3+ / Tm 3 ): a1 In order to prepare the element-labeled lanthanide macrocyclic compound (MMA-DOTA-Tb 3+ / Ho 3+ / Tm 3 ), firstly, MMA-DOTA and lanthanide metal salts were dissolved in 0.5 M NH4AC buffer (pH 5.8) to form 10 mM and 5 mM stock solutions, respectively; a2 10 μL of 10 mM lanthanide and 10 μL of 5 mM MMA-DOTA were mixed and cultured at 37°C with gentle shaking for 1 hour; a3 After the reaction, the prepared lanthanide complex was characterized by electrospray ionization mass spectrometry (ESI-MS); b. Preparation of element-tagged lanthanide macrocyclic compounds (MMA-DOTA-Tb 3+ / Ho 3+ / Tm 3 )-labeled MNAzyme substrate: b1 Dissolve 3′-terminal thiol-labeled ssDNA in 0.5M NH4AC buffer (pH 5.8) at a concentration of 100 μM; b2 Then, incubate 60 μL of ssDNA with 10 mM TCEP at 37°C for 10 min and purify using an ultrafiltration tube; Then, prepare the element-labeled lanthanide macrocyclic compound (MMA-DOTA-Tb 3+ / Ho 3+ / Tm 3 ) was added to the reaction solution and incubated at 37°C for 2 hours; c. Preparation of trivalent DNA tetrahedron (tTDN) c1 Three isotope-labeled DNA tracks, as well as a biotin-labeled DNA (tT) as the fourth backbone of the tTDN structure, were diluted to 8 μM, respectively. At a final concentration of 2 μM, equimolar amounts of the constituent DNA chains were mixed in TM buffer; the mixed chains were heated to 90 °C for 5 min, then rapidly cooled to 4 °C and kept for at least 15 min; d. Construction of trivalent DNA tetrahedron (tTDN)-magnetic beads (MBs) satellite d1 Inactivate RNase on streptavidin-modified magnetic microspheres (SA-MBs): for 100 μL of 10 mg mL -1 SA-MB was washed twice with solution A (solution A: 100 mmol L -1 NaOH, 50 mmol L -1 NaCl), solution B (solution B: 100 mmol L -1 NaCl) and then washed once with B&W buffer (B&W buffer, 10 mmol L -1 Tris-HCland 1mmol L -1 EDTA, 2 mol L -1 NaCl) and then dispersed in 100 μL of B&W buffer; d2 100 μL of SA-MBs were pre-washed with TM buffer before use and then mixed with 500 μL of prepared 2M tTDN. Triple probe tTDN-MBs were formed after incubation at room temperature with gentle shaking for one hour. tTDN was immobilized on the surface of MBs through the specific binding between SA and biotin on tTDN. d3 tTDN-MBs were washed three times with TMR buffer and then used again after being rinsed with TM buffer to remove excess unreacted DNA; e. Multiplex detection of HV69 / 70del, K417N, and T478K based on tTDN-MNAzyme nanosystem: e1 The partzyme A and partzyme B DNA of each MNAzyme were dissolved in TMR buffer to 1 μM in advance, and 5 μL was taken and mixed with 10 μL of the prepared tTDN-MBs; e2. The added volume of analyte samples with different concentrations was unified to 10 μL, and finally the volume of the entire tTDN-MNAzyme nanosystem was supplemented to 100 μL with TMR; e3 was gently shaken at 37°C for 3 hours to allow it to react fully and the isotope probe to be completely sheared; f.ICPMS determination: After magnetic separation, the total volume of reactants and products in the supernatant was 100 μL per tube; it was diluted with 1% HNO3 to a final volume of 1 mL and measured by ICPMS in Tb Ho Tm isotope simultaneous detection mode. BRIEF DESCRIPTION OF THE DRAWINGS
[0004] The present invention will be further described below in conjunction with the accompanying drawings and embodiments: Figure 1 Schematic diagram of the tTDN-MNAzyme sensor for the detection of SARS-CoV-2 RNA mutations. (a) Procedure for labeling orbital strand ssDNA with lanthanide tags. (b) Schematic diagram of the assembly of the MBs-Tb-Ho-Tm tTDN-MNAzyme satellite and the catalytic mechanism of the MNAzyme. (c) Map of the viral genome and the target regions of the three isotopic probes. Workflow for the detection of multiple variant RNA fragments of variants α, β, δ, and ο of HV69 / 70del, K417N, and T478K by ICPMS.
[0005] Figure 2 (a) Signal response of different concentrations of target (b) Signal response of HV 69 / 70del, (c) Signal response of K417N, (d) Signal response of T478K. The inset shows the linear fit of ICPMS signal intensity to the logarithm of RNA concentration. The error bars represent the standard deviation of three independent measurements. (e) Cross-reactivity, (f) Selectivity at 1 pmol of target and 10 pmol of single-base mismatch RNAs, triple-base mismatch RNAs, and non-complementary miRNAs. Where, "SM" is single-base mismatch and "TM" is triple-base mismatch.
[0006] Figure 3 (a) Schematic diagram of the interface sensor with ssDNA and tTDN connected. (b) Comparison of the response of ssDNA probe and tTDN sensor to different concentrations of target RNA. (c) Analytical performance of ssDNA probe and (d) tTDN probe and signal-to-noise ratio at different target concentrations. DETAILED DESCRIPTION
[0007] The above scheme is further described below in conjunction with specific examples. It should be understood that these examples are used for the present invention but are not limited to the scope of the present invention. The experimental methods used in the following examples are all conventional methods unless otherwise specified; the materials, reagents, etc. used in the following examples can be obtained from commercial channels unless otherwise specified. The water used in the following examples is ultrapure water, which is treated by the Milli-Q ultrapure water purification system. All samples in the following examples were not purified before use. The sequences used in the experiment are as follows: Table 1 DNA and RNA sequences used in the present invention Example 1: Exploring the analytical performance of the analytical method of the present invention for multi-component nucleic acid detection After optimizing some reaction conditions, we investigated the analytical performance of the established assay in experiments. In the simultaneous detection strategy, different numbers of RNA fragments (HV69 / 70del, K417N, and T478K) and lanthanide isotopes ( 159 Tb / 165 Ho / 169 The calibration curve was constructed by using the ICPMS signal intensity of Tm. Figure 2 As shown in a, three different target types can be combined and quantified, showing similar trends and performance. After performing logarithmic processing and linear fitting on the data, Figure 2 In the insets of 2b, 2c and 2d, it was found that HV69 / 70del, K417N and T478K had a good linear relationship at 5-2000 fmol, and the relevant equations are shown in Table 2. The detection limits of HV69 / 70del, K417N and T478K calculated by 3σ / k (n=10) were 1.2, 1.5 and 1.1 fmol, respectively.
[0008] Table 2 Analysis performance of ORF1ab / RdRp / E based on ICPMS Example 2: Exploring the selectivity of the analytical method of the present invention for detecting simulated mixed samples There may be a variety of non-target nucleic acid fragments in real samples. Due to the high sequence homology of RNA, we detected a series of sequences like three targets to demonstrate the selectivity of the established strategy. The experimental group contained single mismatch RNA fragments and triple mismatch RNA fragments of HV69 / 70del, K417N and T478K. In addition, random RNA and random DNA fragments were also detected, and the results were similar to those of the blank group, showing the good selectivity of this method.
[0009] Example 3: Exploring the cross-reaction of the analytical method of the present invention in the detection of simulated mixed samples When the sample to be analyzed consists of multiple components, it is necessary to ensure that there is no cross-reaction between the components and cause mutual influence. We experimentally demonstrated the mechanism of this strategy and proved its specificity. We prepared a series of target gene fragment solutions with different components, and the signal intensity of lanthanide metal ions corresponding to different target combinations, 159 Tb / 165 Ho / 169 The signals of Tm under the addition of corresponding RNAs were much higher than their blank signals; whether it was a single component or a mixture of any two components, or even three components tested together, they showed independent and stable results, indicating that the method had reasonable specificity.
[0010] Example 4: Exploring the anti-interference ability and spike recovery rate of the analytical method of the present invention on the actual sample matrix. In this example, the spike recovery experiment of healthy human throat swab samples was used to evaluate the applicability of the method to verify the influence of the sample matrix.
[0011] 1. Sample pretreatment: Use RNA virus extraction kit to break, extract and purify viral nucleic acid from oropharyngeal swabs; 2. Experimental steps: Three oropharyngeal swab extract samples numbered 1#, 2# and 3# were added with 50, 150 and 500 fmol of target RNA HV69 / 70del, K417N and T478K respectively. The stable isotope detection results were substituted into the linear equation to calculate the detection concentration results; 3. Data processing: Substitute the signal intensity results into the linear equation, calculate the measured concentration results, reread three times, and calculate the degree of fit and standard deviation with the results of other methods; 4. Test results: The results are shown in the table. The recovery rates of other matrix samples at different concentrations are in the range of 98.7-101.9%. Therefore, this example adds strong evidence for the tolerance of RNA virus extraction sample matrix and demonstrates the prospect of the inventive method in practical application of experiments.
[0012] Table 3 Results of standard recovery experiments in viral RNA extracts
Claims
1. A method for detecting multi-component variants of the new coronavirus based on a lanthanide-encoded DNA tetrahedron structure, characterized in that Follow these steps: a. Preparation of element-tagged lanthanide macrocyclic compounds (MMA-DOTA-Tb 3+ / Ho 3+ / Tm 3 ): a1 In order to prepare the element-labeled lanthanide macrocyclic compound (MMA-DOTA-Tb 3+ / Ho 3+ / Tm 3 ), firstly, MMA-DOTA and lanthanide metal salts were dissolved in 0.5 M NH4AC buffer (pH 5.8) to form 10 mM and 5 mM stock solutions, respectively; a2 10 μL of 10 mM lanthanide and 10 μL of 5 mM MMA-DOTA were mixed and cultured at 37°C with gentle shaking for 1 hour; a3 After the reaction, the prepared lanthanide complex was characterized by electrospray ionization mass spectrometry (ESI-MS); b. Preparation of element-tagged lanthanide macrocyclic compounds (MMA-DOTA-Tb 3+ / Ho 3+ / Tm 3 )-labeled MNAzyme substrate: b1 Dissolve 3′-terminally thiolated ssDNA in 0.5 M NH4AC buffer (pH 5.8) at a concentration of 100 μM; b2 Then, 60 μL of ssDNA was incubated with 10 mM TCEP at 37 °C for 10 min and purified using an ultrafiltration tube; then, the prepared element-tagged lanthanide macrocyclic compound (MMA-DOTA-Tb 3+ / Ho 3+ / Tm 3 ) was added to the reaction solution and incubated at 37°C for 2 hours; c. Preparation of trivalent DNA tetrahedron (tTDN) c1 Three isotope-labeled DNA tracks, as well as a biotin-labeled DNA (tT) as the fourth backbone of the tTDN structure, were diluted to 8 μM, respectively. At a final concentration of 2 μM, equimolar amounts of the constituent DNA chains were mixed in TM buffer; the mixed chains were heated to 90 °C for 5 min, then rapidly cooled to 4 °C and kept for at least 15 min; d. Construction of trivalent DNA tetrahedron (tTDN)-magnetic beads (MBs) satellite d1 Inactivate RNase on streptavidin-modified magnetic microspheres (SA-MBs): for 100 μL of 10 mg mL -1 SA-MB was washed twice with solution A (solution A: 100 mmol L -1 NaOH, 50 mmol L -1 NaCl), solution B (solution B: 100 mmol L -1 NaCl) and then washed once with B&W buffer (B&W buffer, 10 mmol L -1 Tris-HCl and 1mmol L -1 EDTA, 2 mol L -1 NaCl) and then dispersed in 100 μL of B&W buffer; d2 100 μL of SA-MBs were pre-washed with TM buffer before use and then mixed with 500 μL of prepared 2M tTDN. Triple probe tTDN-MBs were formed after incubation at room temperature with gentle shaking for one hour. tTDN was immobilized on the surface of MBs through the specific binding between SA and biotin on tTDN. d3 tTDN-MBs were washed three times with TMR buffer and then used again after being rinsed with TM buffer to remove excess unreacted DNA; e. Multiplex detection of HV69 / 70del, K417N, and T478K based on tTDN-MNAzyme nanosystem: e1 The partzyme A and partzyme B DNA of each MNAzyme were dissolved in TMR buffer to 1 μM in advance, and 5 μL was taken and mixed with 10 μL of the prepared tTDN-MBs; e2. The added volume of analyte samples with different concentrations was unified to 10 μL, and finally the volume of the entire tTDN-MNAzyme nanosystem was supplemented to 100 μL with TMR; e3 was gently shaken at 37°C for 3 hours to allow it to react fully and the isotope probe to be completely sheared; f.ICPMS determination: After magnetic separation, the total volume of reactants and products in the supernatant was 100 μL per tube; it was diluted with 1% HNO3 to a final volume of 1 mL and measured by ICPMS in Tb Ho Tm isotope simultaneous detection mode.
2. According to claim 1, a method for detecting multi-component variants of the new coronavirus based on a lanthanide-encoded DNA tetrahedron structure, characterized in that: The three nucleic acid variant RNA fragments are obtained by the following method: a. The real sample matrix for the recovery experiment was obtained by RNA virus sample collection tube (inactivated) and EZ-10 spin column virus total RNA extraction kit. First, three human throat swab samples were collected; b. After sampling, place these swabs in a test tube containing 1mL of preservative solution to avoid contact with other parts; break the tip of the swab, discard the stick, and cover the tube containing the sample; shake each swab sample preservation solution on a vortex for half a minute, and then transfer 0.2mL to a 1.5mL plastic centrifuge tube for the second step; c. Add 0.6 mL of Buffer Rlysis-VG to the 0.2 mL sample obtained in the first step, shake for 30 seconds, mix well, and place at room temperature for 10 minutes; add 0.6 mL of absolute ethanol, cover the tube, and vortex for 15 seconds; after a brief centrifugation, transfer 700 μL of the solution to the centrifugal adsorption column and place it at room temperature for 2 minutes; centrifuge at 12,000 rpm for 1 minute at room temperature, discard the permeabilizer, and return the adsorption column to the collection tube; transfer the remaining solution to the centrifugal adsorption column and place it at room temperature for 2 minutes; d. Centrifuge at 12,000 rpm for 1 minute at room temperature, discard the permeabilizing agent, and return the centrifugal adsorption column to the collection tube; add 500 μL of RPE solution to the centrifugal adsorption column, centrifuge at 12,000 rpm for 1 minute at room temperature, discard the permeabilizing agent, and return the centrifugal adsorption column to the collection tube; e. Repeat the last step once, centrifuge at 12,000 rpm for 2 minutes at room temperature; discard the centrifuge tube containing the permeabilization agent; place the centrifuge column in a new homemade RNase-free 1.5 mL centrifuge tube, add 120 μL of DEPC-treated H2O in the middle of the filter membrane of the centrifuge column, and then let it stand at room temperature for 2 minutes; f. Centrifuge at 12,000 rpm for 2 minutes at room temperature; finally, add a certain amount of target RNA fragments to the sample in the collection tube; add 20 μL of spiked sample to each reaction system.
